First AD

Second AD

News

Multiple Sclerosis

EMD-22-NRD0193 - /clinical/multiple-sclerosis

 multiple sclerosis (MS) clinical focus page offers information, podcasts, videos, and news about the latest study and clinical trial findings, FDA actions, clinical guideline updates, and expert interviews related to the care and management of patients with MS, including relapsing MS and progressive MS, as well as related disorders such as neuromyelitis optica spectrum disorder.

Conferences

Rapid Readout: Clinical Updates in Multiple Sclerosis From CMSC 2020

News Network

Consortium of Multiple Sclerosis Centers Annual Meeting

Ocrelizumab Compared to Glatiramer Acetate and Dimethyl Fumarate for MS

The Multidisciplinary Theme of CMSC 2020

Progressive MS: The 2020 Whitaker Lecture

Post Hoc Analysis: Phase 3 ASCLEPIOS I and II Trials in Relapsing MS

Primary Results From the ENSEMBLE PLUS Study

Post Hoc Analysis: Phase 3 EXPAND Trial in Secondary Progressive MS

Open-Label Extension: Phase 3 OPERA I and II Trials in Relapsing MS

CMSC Data Release: Abstract DXT58 and MS Risk Reduction

Open-Label Extension: BTKI in Relapsing MS Over 108 Weeks

Ocrelizumab Compared to Glatiramer Acetate and Dimethyl Fumarate for MS

Latest News